SignalCorporate
13F-HR - Patient Capital Management (0001854794) (FILER) - SEC
📊 Patient Capital 13F — Patient Capital Management, LLC: $3.1B portfolio, 41 positions (Q3 2026)
What changed
📊 Patient Capital 13F — Patient Capital Management, LLC: $3.1B portfolio, 41 positions (Q3 2026)
1. ROYALTY PHARMA PLC — $200M (6.3%)
2. C — $180M (5.7%)
3. GOOGL — $178M (5.7%)
4. AMZN — $169M (5.4%)
5. NVDA — $162M (5.2%)
6. UNH — $156M (5.0%)
7. PGEN — $154M (4.9%)
8. META — $131M (4.2%)
9. QXO — $128M (4.1%)
10. CHYM — $126M (4.0%)
11. META PLATFORMS INC — $124M (4.0%)
12. ET — $119M (3.8%)
13. ADBE — $96M (3.1%)
14. FBTC — $89M (2.8%)
15. NORWEGIAN CRUISE LINE HLDGS — $88M (2.8%)
16. COIN — $86M (2.7%)
17. CROX — $86M (2.7%)
18. SEADRILL LTD — $85M (2.7%)
19. PPLI — $84M (2.7%)
20. AVGO — $84M (2.7%)
… (+21 more)
Why it matters
📊 Patient Capital 13F — Patient Capital Management, LLC: $3.1B portfolio, 41 positions (Q3 2026)